BioAge Labs, Inc. Share Price
NASDAQ: BIOA | Micro CapBioAge Labs, Inc. Stock Performance
BioAge Labs, Inc. Share Price Today
As of 30 October 2026, BioAge Labs, Inc.'s share price is $5.95. The stock opened at $5.85, compared to its previous close of $5.95. During today's trading session, BioAge Labs, Inc.'s share price traded between $5.85 and $6.24, with an average price of $6.04. Over the past 52 weeks, the stock has recorded a high of $25.88 and a low of $4.82. In terms of performance, BioAge Labs, Inc.'s share price has declined by 64.56% over the last six months and is down 21.40% on a year-on-year basis.
BioAge Labs, Inc. Share Price Chart
BioAge Labs, Inc. Quarterly Profit & Loss
All figures in USD
BioAge Labs, Inc. Annual Profit & Loss
All figures in USD
About BioAge Labs, Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
BioAge Labs, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $7.06 | $5.94 | -16.16% |
Sep 2026 | $9.38 | $7.08 | -29.71% |
Aug 2026 | $9.61 | $10.08 | +11.50% |
Jul 2026 | $24.30 | $9.04 | -63.10% |
Jun 2026 | $17.16 | $24.50 | +41.91% |
May 2026 | $16.63 | $17.27 | +2.83% |
Apr 2026 | $17.91 | $16.79 | -4.03% |
Mar 2026 | $20.10 | $17.50 | -21.34% |
Feb 2026 | $19.73 | $22.24 | +16.90% |
Jan 2026 | $12.70 | $19.02 | +43.97% |
Dec 2025 | $9.14 | $13.21 | +40.14% |
Nov 2025 | $7.57 | $9.43 | +24.57% |